Development of a [177Lu]BPAMD labeling kit and an automated synthesis module for routine bone targeted endoradiotherapy.

MLA

Meckel, Marian, et al. “Development of a [177Lu]BPAMD Labeling Kit and an Automated Synthesis Module for Routine Bone Targeted Endoradiotherapy.” Cancer Biotherapy & Radiopharmaceuticals, vol. 30, no. 2, Mar. 2015, pp. 94–99. EBSCOhost, https://doi.org/10.1089/cbr.2014.1720.

APA

Meckel, M., Nauth, A., Timpe, J., Zhernosekov, K., Puranik, A. D., Baum, R. P., & Rösch, F. (2015). Development of a [177Lu]BPAMD labeling kit and an automated synthesis module for routine bone targeted endoradiotherapy. Cancer Biotherapy & Radiopharmaceuticals, 30(2), 94–99. https://doi.org/10.1089/cbr.2014.1720

Chicago

Meckel, Marian, Alexander Nauth, Jan Timpe, Konstantin Zhernosekov, Ameya D Puranik, Richard P Baum, and Frank Rösch. 2015. “Development of a [177Lu]BPAMD Labeling Kit and an Automated Synthesis Module for Routine Bone Targeted Endoradiotherapy.” Cancer Biotherapy & Radiopharmaceuticals 30 (2): 94–99. doi:10.1089/cbr.2014.1720.